Compare Cara Therapeutics vs Lead Pharma
Customers evaluate the quality of Cara Therapeutics's products using the following success metrics.
Overview
Cara Therapeutics is 20 yrs old and is based in United States.
Cara Therapeutics is a commercial-stage biopharmaceutical company that focuses on improving the lives of patients suffering from pruritus. The company's main offering is a treatment for moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis, and it is also developing treatments for pruritus in patients with non-dialysis dependent advanced chronic kidney disease, atopic dermatitis, and notalgia paresthetica. It was founded in 2004 and is based in Stamford, Connecticut.
Lead Pharma is based in Netherlands
Lead Pharma is a clinical-stage pharmaceutical research and development company, operating in the healthcare and pharmaceutical industry. The company's main focus is on designing and developing innovative small-molecule therapies, primarily aimed at treating autoimmune diseases and cancer. Lead Pharma primarily serves the healthcare sector, with a particular emphasis on the pharmaceutical industry. It is based in Oss, Netherlands.
Demo Video
Leadership
Derek Chalmers (Chief Executive Officer, President)
Frans van den Berg (Chief Executive Officer)
Funding
Investors
Ascent Biomedical Ventures, Mitsubishi Corporation Life Sciences Ventures
Roche, PPM Oost
Product
Information not available because Cara Therapeutics has not claimed their profile.
Work for Cara Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Cara Therapeutics?
Claim your profile now.
Why Lead Pharma beats Cara Therapeutics
Benefits
- Innovation
- Technical experttise
- Unique characteristics
Products
Pipelines products in oncology or immunology
Innovative new small molecule in oncology or immunology
Customers
Known Partners
Why They Buy